Clinical trial
Standard vs. Reduced-Intensity Conditioning in Patients With Acute Myeloid…
NCT00150878 · University Hospital Carl Gustav Carus, Other · Terminated
Key facts
| NCT number | NCT00150878 |
|---|---|
| Title | Standard vs. Reduced-Intensity Conditioning in Patients With Acute Myeloid Leukemia in First Remission |
| Official title | Randomized Phase III Comparison of 12 Gy TBI and Cyclophosphamide 120 mg/kg With Fludarabine 120 mg/Sqm and 8 Gy TBI Before Allogeneic Transplantation in Patients With Acute Myeloid Leukemia in First Remission |
| Lead sponsor | University Hospital Carl Gustav Carus, Other |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Acute Myeloid Leukemia |
| Intervention type | Other |
| Interventions | Conditioning therapy |
| Enrollment | 198 |
| Start date | Dec 1, 2003 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2010 |
| First posted | Sep 8, 2005 |
| Last update posted | Jun 20, 2013 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: